• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

卵巢肿瘤中蛋白质表达的二维凝胶分析显示肿瘤内异质性程度较低。

Two-dimensional gel analysis of protein expression in ovarian tumors shows a low degree of intratumoral heterogeneity.

作者信息

Alaiya A A, Franzén B, Moberger B, Silfverswärd C, Linder S, Auer G

机构信息

Department of Oncology-Pathology, Cancer Center Karolinska, Karolinska Institute and Hospital, Stockholm, Sweden.

出版信息

Electrophoresis. 1999 Apr-May;20(4-5):1039-46. doi: 10.1002/(SICI)1522-2683(19990101)20:4/5<1039::AID-ELPS1039>3.0.CO;2-4.

DOI:10.1002/(SICI)1522-2683(19990101)20:4/5<1039::AID-ELPS1039>3.0.CO;2-4
PMID:10344283
Abstract

The process of tumor progression leads to the emergence of multiple clones, and to the development of tumor heterogeneity. One approach to the study of the extent of such heterogeneity is to examine the expression of marker proteins in different tumor areas. Two-dimensional gel electrophoresis (2-DE) is a powerful tool for such studies, since the expression of a large number of polypeptide markers can be evaluated. In the present study, tumor cells were prepared from human ovarian tumors and analyzed by 2-DE and PDQUEST. As judged from the analysis of two different areas in each of nine ovarian tumors, the intratumoral variation in protein expression was low. In contrast, large differences were observed when the protein profiles of different tumors were compared. The differences in gene expression between pairs of malignant carcinomas were slightly larger than the differences observed between pairs of benign tumors. We conclude that 2-DE analysis of intratumoral heterogeneity in ovarian cancer tissue indicates a low degree of heterogeneity.

摘要

肿瘤进展过程会导致多个克隆的出现以及肿瘤异质性的发展。研究这种异质性程度的一种方法是检测不同肿瘤区域中标记蛋白的表达。二维凝胶电泳(2-DE)是进行此类研究的有力工具,因为可以评估大量多肽标记物的表达。在本研究中,从人卵巢肿瘤中制备肿瘤细胞,并通过2-DE和PDQUEST进行分析。根据对九个卵巢肿瘤中每个肿瘤的两个不同区域的分析判断,肿瘤内蛋白质表达的差异较小。相比之下,当比较不同肿瘤的蛋白质谱时,观察到了很大差异。恶性癌对之间的基因表达差异略大于良性肿瘤对之间观察到的差异。我们得出结论,对卵巢癌组织中肿瘤内异质性的2-DE分析表明异质性程度较低。

相似文献

1
Two-dimensional gel analysis of protein expression in ovarian tumors shows a low degree of intratumoral heterogeneity.卵巢肿瘤中蛋白质表达的二维凝胶分析显示肿瘤内异质性程度较低。
Electrophoresis. 1999 Apr-May;20(4-5):1039-46. doi: 10.1002/(SICI)1522-2683(19990101)20:4/5<1039::AID-ELPS1039>3.0.CO;2-4.
2
An immunohistochemical comparison between low-grade and high-grade ovarian serous carcinomas: significantly higher expression of p53, MIB1, BCL2, HER-2/neu, and C-KIT in high-grade neoplasms.低级别与高级别卵巢浆液性癌的免疫组化比较:在高级别肿瘤中,p53、MIB1、BCL2、HER-2/neu和C-KIT的表达显著更高。
Am J Surg Pathol. 2005 Aug;29(8):1034-41.
3
Serous and mucinous ovarian tumors express different profiles of MMP-2, -7, -9, MT1-MMP, and TIMP-1 and -2.浆液性和黏液性卵巢肿瘤表达不同的基质金属蛋白酶-2、-7、-9、膜型基质金属蛋白酶-1及组织金属蛋白酶抑制因子-1和-2谱。
Int J Oncol. 2008 Dec;33(6):1239-46.
4
[Expression of the cdx2 gene in benign intestinal-type mucinous ovarian tumors].[cdx2基因在良性肠型黏液性卵巢肿瘤中的表达]
Pathologica. 2003 Aug;95(4):185-91.
5
Metallothionein expression and nuclear size in benign, borderline, and malignant serous ovarian tumours.金属硫蛋白在良性、交界性和恶性浆液性卵巢肿瘤中的表达及细胞核大小
J Pathol. 1999 Sep;189(1):60-5. doi: 10.1002/(SICI)1096-9896(199909)189:1<60::AID-PATH387>3.0.CO;2-J.
6
Expression of extracellular matrix proteins in ovarian serous tumors.卵巢浆液性肿瘤中细胞外基质蛋白的表达
Int J Gynecol Pathol. 2007 Apr;26(2):141-6. doi: 10.1097/01.pgp.0000229994.02815.f9.
7
Expression levels of the nerve growth factor receptors TrkA and p75 in effusions and solid tumors of serous ovarian carcinoma patients.浆液性卵巢癌患者的积液和实体瘤中神经生长因子受体TrkA和p75的表达水平。
Clin Cancer Res. 2001 Nov;7(11):3457-64.
8
[Proteomic analysis of human ovarian cancer cell lines and their platinum-resistant clones].[人卵巢癌细胞系及其铂耐药克隆的蛋白质组学分析]
Zhonghua Fu Chan Ke Za Zhi. 2006 Sep;41(9):584-7.
9
Analysis of polypeptide expression in benign and malignant human breast lesions.
Electrophoresis. 1997 Mar-Apr;18(3-4):582-7. doi: 10.1002/elps.1150180341.
10
Heterogeneous genetic alterations in ovarian mucinous tumors: application and usefulness of laser capture microdissection.卵巢黏液性肿瘤中的异质性基因改变:激光捕获显微切割的应用及效用
Hum Pathol. 2001 Nov;32(11):1203-8. doi: 10.1053/hupa.2001.28956.

引用本文的文献

1
Histopathological markers of treatment response and recurrence risk in ovarian cancers and borderline tumors.卵巢癌和交界性肿瘤治疗反应及复发风险的组织病理学标志物
Pathologe. 2017 Nov;38(Suppl 2):180-191. doi: 10.1007/s00292-017-0375-9.
2
Protein signatures as potential surrogate biomarkers for stratification and prediction of treatment response in chronic myeloid leukemia patients.蛋白质特征作为慢性髓性白血病患者分层和治疗反应预测的潜在替代生物标志物。
Int J Oncol. 2016 Sep;49(3):913-33. doi: 10.3892/ijo.2016.3618. Epub 2016 Jul 7.
3
Human cervicovaginal fluid biomarkers to predict term and preterm labor.
用于预测足月和早产的人宫颈阴道液生物标志物。
Front Physiol. 2015 May 13;6:151. doi: 10.3389/fphys.2015.00151. eCollection 2015.
4
Differential marker expression by cultures rich in mesenchymal stem cells.富含间充质干细胞的培养物中的差异标志物表达。
BMC Cell Biol. 2013 Dec 5;14:54. doi: 10.1186/1471-2121-14-54.
5
Variation in cell signaling protein expression may introduce sampling bias in primary epithelial ovarian cancer.细胞信号蛋白表达的变化可能会给原发性卵巢上皮癌的样本采集带来偏差。
PLoS One. 2013 Oct 28;8(10):e77825. doi: 10.1371/journal.pone.0077825. eCollection 2013.
6
Proteomic contributions to personalized cancer care.蛋白质组学对个性化癌症治疗的贡献。
Mol Cell Proteomics. 2008 Oct;7(10):1780-94. doi: 10.1074/mcp.R800002-MCP200. Epub 2008 Jul 29.
7
Protein expression patterns in primary carcinoma of the vagina.阴道原发性癌中的蛋白质表达模式。
Br J Cancer. 2004 Jul 19;91(2):319-26. doi: 10.1038/sj.bjc.6601944.
8
Identification and validation of metastasis-associated proteins in head and neck cancer cell lines by two-dimensional electrophoresis and mass spectrometry.通过二维电泳和质谱法鉴定及验证头颈癌细胞系中与转移相关的蛋白质
Clin Exp Metastasis. 2002;19(4):319-26. doi: 10.1023/a:1015515119300.